AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Close
Create a link to this page
Copy and paste this link tag into your Web page or blog:
<a href="http://www.accessmylibrary.com/coms2/summary_0286-4380703_ITM" title="Facts and information about Enjuvia approved.(Products)">Enjuvia approved.(Products)</a>
Close
Set up an RSS feed that alerts you when new articles from OB GYN News are available.
Frequently asked questions about RSS feeds
Enjuvia approved.(Products)
Enjuvia (synthetic conjugated estrogens, B) in tablets of 0.625 mg and 1.25 mg is approved for the treatment of moderate to severe ...
Related articles from newspapers, magazines, journals, and more
For more facts and information, see all results
- Enjuvia approved.(RXs)(Barr Pharmaceuticals Inc.)(Brief Article)
- Magazine article from: Chain Drug Review June 7, 2004 700+ words
Barr Pharmaceuticals Inc. has received Food and Drug Administration approval for Enjuvia 0.625- and 1.25-mg tablets. The branded product...
- Enjuvia approved.(Products)(Brief Article)
- Magazine article from: Family Practice News July 1, 2004 700+ words
Enjuvia (synthetic conjugated estrogens, B) in 0.625 mg and 1.25 mg tablets is approved for moderate to severe vasomotor symptoms associated with menopause. For more information, call Barr Pharmaceuticals Inc., 800-222-0190 or 201-930-3302.
- Barr Pharmaceuticals Inc, a Company Analysis Including 16 Deals Made, and 21...
- Press release article from: Business Wire November 7, 2005 700+ words
...has announced the addition of Barr Pharmaceuticals Inc Deals Briefing to their offering. Description Barr Pharmaceuticals Inc Deals briefing provides...view of the 16 deals made by Barr Pharmaceuticals Inc and its subsidiaries with...
- Trade Alert for Barr Pharmaceuticals Inc.
- Press release article from: M2 Presswire May 10, 2007 700+ words
...May 2007-Biotech News: Trade Alert for Barr Pharmaceuticals Inc(C)1994-2007 M2 COMMUNICATIONS LTD RDATE:10052007 Trade Alert for Barr Pharmaceuticals Inc (NYSE:BRL) Barr Pharmaceuticals, Inc. engages in the development, manufacture...
- /C O R R E C T I O N -- Barr Pharmaceuticals, Inc. (NYSE: BRL)/.
- Press release article from: PR Newswire August 21, 2008 700+ words
In the news release, Barr Pharmaceuticals, Inc. (NYSE: BRL...yesterday, Aug. 20, by Barr Pharmaceuticals, Inc. over PR Newswire...release changed to, "Barr Pharmaceuticals, Inc. (NYSE: BRL...
- Barr Changes State of Incorporation to Delaware; Company changes Name to Barr...
- Press release article from: PR Newswire January 2, 2004 700+ words
Barr Pharmaceuticals, Inc. today announced that...Barr Laboratories, Inc. into Barr Pharmaceuticals, Inc., which is incorporated...Company's corporate name became Barr Pharmaceuticals, Inc. As a result of the reincorporation...
- Barr Pharmaceuticals, Inc. - Financial and Strategic Analysis Review.
- Press release article from: M2 Presswire May 6, 2009 700+ words
...companiesandmarkets.com: Barr Pharmaceuticals, Inc. - Financial and Strategic...companiesandmarkets.com adds new report: Barr Pharmaceuticals, Inc. - Financial and Strategic Analysis Review Barr Pharmaceuticals, Inc. - Financial and Strategic...
- Barr Pharmaceuticals Inc. Review in Progress.
- Press release article from: M2 Presswire March 28, 2008 700+ words
...March 2008-The Maybach Journal: Barr Pharmaceuticals Inc. Review in Progress(C)1994...March 28, 2008, we have added Barr Pharmaceuticals Inc. (NYSE:BRL) to the list...numerous publicly traded companies Barr Pharmaceuticals Inc. was up over $0.05 on below...
- Progressive Following on Barr Pharmaceuticals Inc.
- Press release article from: M2 Presswire March 28, 2008 700+ words
...Corner: Progressive Following on Barr Pharmaceuticals Inc.(C)1994-2008 M2 COMMUNICATIONS...resumed our progressive review of Barr Pharmaceuticals Inc. (NYSE:BRL) as it opened...various prospective companies therein Barr Pharmaceuticals Inc. was among those that we have...
- Event Brief of Barr Pharmaceuticals, Inc. Conference Call to discuss the...
- News wire article from: Fair Disclosure Wire May 12, 2006 700+ words
...WIRE PARTICIPANTS . Carol Cox, Barr Pharmaceuticals, Inc., VP of IR . Bruce Downey, Barr Pharmaceuticals, Inc., Chairman and CEO...Analyst . Carole Ben-Maimon, Barr Pharmaceuticals, Inc., President and COO of...
Source: HighBeam Research, Enjuvia approved.(Products)